Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method

Hypertension Research

Volumn 32, Issue 12, 2009, Pages 1091-1096

  Araki, Shuichiro ^a   Hirooka, Yoshitaka ^a   Kishi, Takuya ^a   Yasukawa, Keiji ^b   Utsumi, Hideo ^b   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin receptor blocker; Brain; Oxidative stress; Sympathetic nervous system

Indexed keywords

HYDRALAZINE; HYDROCHLOROTHIAZIDE; NORADRENALIN; OLMESARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HEART RATE; HYPERTENSION; IN VIVO STUDY; MALE; NONHUMAN; NORADRENALIN URINE LEVEL; OXIDATIVE STRESS; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; ELECTRON SPIN RESONANCE SPECTROSCOPY; HEART RATE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMIDAZOLES; MALE; NADPH OXIDASE; NOREPINEPHRINE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STROKE; TETRAZOLES;

EID: 73849116449     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.160     Document Type: Article

References (53)

1. Phillips MI, Sumners C. Angiotensin II in the central nervous system physiology. Regul Pept 1998; 78: 1-11.
2. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FAO. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 2003; 35: 901-918.
3. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-364.
4. Oshima N, Kumagai H, Onimaru H, Kawai A, Pilowsky PM, Iigaya K, Takimoto C, Hayashi K, Saruta T, Itoh H. Monosynaptic excitatory connection from the rostral ventrolateral medulla to sympathetic preganglionic neurons revealed by simultaneous recordings. Hypertens Res 2008; 31: 1445-1454.
5. Saavedra JM. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 2005; 25: 485-512.
6. 1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res 2004; 1028: 9-18.
7. 1 receptor blockers and pressor responses to central angiotensin II and sodium. Can J Physiol Pharmacol 2001; 79: 861-867.
8. 1 receptor blockers. J Cardiovasc Pharmacol 2003; 41: 593-599.
9. Gohlke P, von Kügelgen S, Jügensen T, Kox T, Rascher W, Culman J, Unger T. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J Hypertens 2002; 20: 909-918. (Pubitemid 34913672)
10. 1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther 2001; 298: 62-70.
11. Hirooka Y. Role of ROS in brainstem in neural mechanisms of hypertension. Auton Neurosci 2008; 142: 20-24.
12. Peterson JR, Shrama RV, Davisson RL. Reactive oxygen species in the neuropathogen-esis of hypertension. Curr Hypertens Rep 2006; 8: 232-241.
13. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased ROS in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-2362.
14. Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A, Sunagawa K. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res 2005; 96: 252-260.
15. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95: 532-539.
16. Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition of Rac1-derived ROS in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension 2007; 50: 62-68.
17. 1) receptor in the rostral ventrolateral medulla in rats. J Appl Physiol 2002; 92: 2153-2161.
18. Koga Y, Hirooka Y, Araki S, Nozoe M, Kishi T, Sunagawa K. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens Res 2008; 31: 2075-2083.
19. Scott LJ, McCormack PL. Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs 2008; 68: 1239-1272.
20. 1 receptor antagonist. J Hypertens 2001; 19(Suppl 1): S3-S14.
21. Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang GX, Kimura S, Abe Y, Nishiyama A. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2004; 27: 493-500.
22. Utsumi H, Muto E, Masuda S, Hamada A. In vivo ESR measurement of free radicals in whole mice. Biochem Biophys Res Commun 1990; 172: 1342-1348.
23. Miura Y, Ozawa T. Noninvasive study of radiation-induced oxidative damage using in vivo electron spin resonance. Free Radic Biol Med 2000; 28: 854-859.
24. Sonta T, Inoguchi T, Matsumoto S, Yasukawa K, Inuo M, Tsubouchi H, Sonoda N, Kobayashi K, Utsumi H, Nawata H. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem Biophys Res Commun 2005; 330: 415-422.
25. Miller Jr FJ, Griendling KK. Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol 2002; 353: 220-233.
26. Sano H, Matsumoto K, Utsumi H. Synthesis and imaging of blood-brain-barrier permeable nitroxyl-probes for free radical reactions in brain of living mice. Biochem Mol Biol Int 1997; 42: 641-647.
27. Sano H, Naruse M, Matsumoto K, Oi T, Utsumi H. A new nitroxyl-probe with high retention in the brain and its application for brain imaging. Free Radic Biol Med 2000; 28: 959-969.
28. Anzai K, Saito K, Takeshita K, Takahashi S, Miyazaki H, Shoji H, Lee M-C, Masumizu T, Ozawa T. Assessment of ESR-CT imaging by comparison with autoradiography for the distribution of a blood-brain-barrier permeable spin probe, MC-PROXYL, to rodent brain. Magn Reson Imaging 2003; 21: 765-772.
29. Swartz HM, Sentjurc M, Morse II PD. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim Biophys Acta 1986; 888: 82-91.
30. Takeshita K, Saito K, Ueda J, Anzai K, Ozawa T. Kinetic study on ESR signal decay of nitroxyl radicals, potent redox probes for in vivo ESR spectroscopy, caused by ROS. Biochim Biophys Acta 2002; 1573: 156-164.
31. Kinugawa S, Post H, Kaminski PM, Zhang X, Xu X, Huang H, Recchia A, Ochoa M, Wolin MS, Kaley G, Hintze TH. Coronary microvascular endothelial stunning after acute pressure overload in the conscious dog is caused by oxidant processes: the role of angiotensin II type 1 receptor and NAD(P)H oxidase. Circulation 2003; 108: 2934-2940.
32. Martz D, Rayos G, Schielke GP, Betz AL. Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke 1989; 20: 488-494.
33. Giray B, Gürbay A, Hincal F. Cypermethrin-induced oxidative stress in rat brain and liver is prevented by Vitamin E or allopurinol. Toxicol Lett 2001; 118: 139-146.
34. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press: New York, 1998.
35. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K, Takeshita A. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000; 86: 152-157.
36. Shiba T, Yamato M, Kudou W, Ichikawa K, Yamada K-I, Watanabe T, Utsumi H. Analysis of nitroxyl spin probes in mouse brain by X-band ESR with microdialysis technique. J Pharm Sci 2008; 97: 4101-4107.
37. Lee M-C, Shoji H, Miyazaki H, Yoshino FT, Hori N, Toyoda M, Ikeda Y, Anzai K, Ikota N, Ozawa T. Assessment of oxidative stress in the spontaneously hypertensive rat brain using electron spin resonance (ESR) imaging and in vivo L-band ESR. Hypertens Res 2004; 27: 485-492.
38. Igase M, Kohara K, Nagai T, Miki T, Ferrario CM. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade. Hypertens Res 2008; 31: 553-559.
39. Matsumura K, Averill DB, Ferrario CM. Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol 1998; 275: R1611-R1619.
40. Lin Y, Matsumura K, Kagiyama S, Fukuhara M, Fujii K, Iida M. Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR. Brain Res 2005; 1058: 161-166.
41. Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M. Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR. J Hypertens 1999; 17: 917-922.
42. Hirooka Y, Potts PD, Dampney RAL. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res 1997; 772: 107-114.
43. Ye S, Zhong H, Duong VN, Campese V. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 2002; 39: 1101-1106.
44. 1-receptor blockers. J Hum Hypertens 2002; 16: S64-S70.
45. Ueno M, Sakamoto H, Liao Y-J, Onodera M, Huang C-L, Miyanaka H, Nakagawa T. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol 2004; 122: 131-137. (Pubitemid 39222746)
46. Lippoldt A, Kniesel U, Liebner S, Kalbacher H, Kirsch T, Wolburg H, Haller H. Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Res 2000; 885: 251-261.
47. Iwanami J, Mogi M, Iwai M, Horiuchi M. Inhibition of the renin-angiotensin system and target organ protection. Hypertens Res 2009; 32: 229-237.
48. Saxby BK, Harrington F, Wenes KA, McKeith IG, Ford GA. Candesartan and cognitive decline in older patients with hypertension. Neurology 2008; 70: 1858-1866.
49. Mogi M, Tsukuda K, Li J-M, Iwanami J, Min L-J, Sakata A, Fujita T, Iwai M, Horiuchi M. Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan. Neuropharmacology 2007; 53: 899-905.
50. Hirooka Y, Kimura Y, Nozoe M, Sagara Y, Ito K, Sunagawa K. Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hypertens Res 2006; 29: 49-56.
51. Kishi T, Hirooka Y, Shimokawa H, Takeshita A, Sunagawa K. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 2008; 30: 1-9.
52. Konno S, Hirooka Y, Araki S, Koga Y, Kishi T, Sunagawa K. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2008; 52: 555-560.
53. 15N-labeled nitroxyl radicals. Proc Natl Acad Sci USA 2006; 103: 1463-1468. (Pubitemid 43191188)